Carson Wealth (CWM LLC)
GPCR icon

Carson Wealth (CWM LLC)’s Structure Therapeutics GPCR Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.03K Sell
125
-355
-74% -$24.3K ﹤0.01% 4961
2025
Q4 		$33K Buy
480
+125
+35% +$5.1K ﹤0.01% 3887
2025
Q3 		$10K Hold
355
– – ﹤0.01% 4471
2025
Q2 		$7K Buy
355
+255
+255% +$5.61K ﹤0.01% 4450
2025
Q1 		$2K Hold
100
– – ﹤0.01% 4756
2024
Q4 		$3K Buy
+100
New +$3.55K ﹤0.01% 4408

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Carson Wealth (CWM LLC)'s GPCR Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Structure Therapeutics (GPCR) stake by 74% in Q1 2026, selling an estimated $24.3K and leaving 125 shares worth $6.03K. The position accounts for ﹤0.01% of the portfolio, ranked #4961.

Carson Wealth (CWM LLC) first reported a position in GPCR in Q4 2024 and has held it in 6 quarters since. The position peaked at $33K in Q4 2025. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Carson Wealth (CWM LLC) held 125 shares of Structure Therapeutics worth $6.03K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 355 Structure Therapeutics shares in Q1 2026, an estimated $24.3K.
  • Structure Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4961 holding.
  • Carson Wealth (CWM LLC) first reported a position in Structure Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Carson Wealth (CWM LLC)'s Structure Therapeutics position peaked at $33K in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.